GLP-1 use has been shown to lead to meaningful weight loss and to greatly reduce the likelihood of conditions and complications associated with obesity, such as cardiovascular disease, and some GLP-1s have also been associated with other desirable health outcomes, such as decreased risk of depression or anxiety
The body determines where fat is stored and where it is lost based on factors such as: Genetics Hormones Age Overall body composition If someone loses weight while using BPC-157, there is no evidence suggesting the peptide specifically targets fat around the stomach
The FDA-approved prescribing information for Zepbound does not list NAION as a known adverse effect, and the medication's clinical trial program did not identify a safety signal for this condition
(That's a positive sign for ingredient freshness, but it may limit availability in more rural or less-populated areas.) From there, you can filter by calorie level, protein-forward meals, vegetarian, dairy-free, low-carb, and more
What biohackers like about MK-677 is its ability to promote deep REM cycle sleep
One of the exciting peptides in this field is CJC-1295